Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
about
The diagnosis of chronic obstructive pulmonary disease.Effects of Long-Term Exposure to Traffic-Related Air Pollution on Lung Function in ChildrenClinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with AsthmaChanges in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study.Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children.How "healthy" should children be when selecting reference samples for spirometry?Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data.Maximal mid-expiratory flow is a surrogate marker of lung clearance index for assessment of adults with bronchiectasisThe Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study.Putting lung function and physiology into perspective: cystic fibrosis in adults.Pulmonary physiology: future directions for lung function testing in COPD.Chronic Obstructive Pulmonary Disease and its Non-Smoking Risk Factors in India.Platelet distribution width as a prognostic factor in patients with COPD - pilot study.Pattern of Lung Function Is Not Associated with Prior or Future Morbidity in Children with Sickle Cell Anemia.Reference values for spirometry and their use in test interpretation: A Position Statement from the Australian and New Zealand Society of Respiratory Science.Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?Small airways disease: time for a revisit?Lung structure-function correlation in patients with primary ciliary dyskinesia.Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.Obstruction phenotype as a predictor of asthma severity and instability in children.Inter-test reproducibility of the lung clearance index measured by multiple breath washout.Fetal and Infant Growth Patterns and Risk of Lower Lung Function and Asthma. The Generation R Study.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.Reference Equations for Spirometry in the Canadian Population.Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.Using lung function measurements to greater advantage in patients with lung disease: which test and when?Tobacco smoke exposure in early life and adolescence in relation to lung function.Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation
P2860
Q27026678-06E1A89A-F89E-4F00-AD64-6332F0EA4758Q30234343-FBB059DA-6136-41FB-A2E5-262E93FCD1EBQ30277842-8AA5DE8A-B427-4CA8-B89C-FCBE57ABEDECQ33766444-A11B071D-6036-4A3D-AAD7-F23106E6C183Q33811274-31A8EEB2-BB92-4D54-B15F-8EE5804D3B74Q35674437-BA08AE1E-84D3-441E-994E-B65FB6C4E2E8Q36373826-FC3BB6B9-6C16-4AE0-BAD7-D4E5E08C4D07Q37035052-69144ED2-94C9-46B0-AD38-31EAD5971906Q37641385-3A4F623C-1DF8-4EC2-8895-BAE95D3F9276Q38248996-E207DA6D-8B2C-433C-955F-0395FCF41D05Q38254519-EEA351C4-ABA4-4A33-AD97-908A50F76916Q38603104-98FAFAEC-52B6-4C1C-A4B4-72125CEF297DQ38621357-90C0E1A1-68A6-43B0-B081-2207A9C1A1D8Q38853355-B74E594A-7F92-422C-8C94-208CEED96C12Q39560303-092993C3-F958-4474-88BE-2841323E7F29Q40831123-B565B209-AB0B-4F97-AF93-C2547E0A2227Q41405553-A1C40002-1D44-423B-AE85-9E7B56BF169AQ41489195-FD8EC298-4AEB-4331-8E76-F5E42431BD2AQ41687136-36A5935C-82BA-454C-BC3C-C411955662E7Q47387538-D51A4BBF-AD96-4E71-B351-C3415051B74EQ47583247-8EE0390F-8BCF-4ED4-AE8B-A0C2BA958BDCQ47677495-D046D4FC-780E-496A-B7FD-6BFB82797814Q47767721-3104D7E5-1E95-4BE8-9672-1C1D3B19D2C9Q49346082-6C86602E-8B6F-42A7-AD7D-3F6CA114CBB7Q49996636-0DA25E77-1811-403C-B96A-2CB50FA3F55DQ50664371-C2210461-1767-4F87-89EB-080BE997EE74Q51640117-B4C68646-434B-4598-ADC0-45CB9F0484A1Q51714613-BA772039-5E4F-402B-9CD9-42B1F5AEBD23Q55221976-DEB43A1C-0BE1-4D8E-81D8-D6913E411742Q58415903-B4A0F555-4BC7-4C25-A284-32D9AAAB3FFD
P2860
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@en
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@nl
type
label
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@en
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@nl
prefLabel
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@en
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.
@nl
P2093
P1476
Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making
@en
P2093
Danny J Brazzale
Jeffrey J Pretto
Philip H Quanjer
P304
P356
10.1183/09031936.00128113
P577
2013-09-26T00:00:00Z